Scientific article
OA Policy
English

Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique

Published inClinical and Experimental Rheumatology, vol. 29, no. 2 Suppl 65, p. S40-45
Publication date2011
Abstract

To obtain experiences and expert opinion on treatment of SSc patients with TNF-α antagonists.

Keywords
  • Anti-Inflammatory Agents/administration & dosage/adverse effects
  • Arthritis/drug therapy/etiology/immunology/pathology
  • Consensus
  • Delphi Technique
  • Disease Progression
  • Fibrosis
  • Humans
  • Immunologic Factors/administration & dosage/adverse effects
  • Inflammation
  • Off-Label Use
  • Scleroderma, Systemic/complications/drug therapy/pathology
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors
Citation (ISO format)
DISTLER, Joerg H W et al. Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique. In: Clinical and Experimental Rheumatology, 2011, vol. 29, n° 2 Suppl 65, p. S40–45.
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN0392-856X
522views
959downloads

Technical informations

Creation09/12/2014 09:45:00
First validation09/12/2014 09:45:00
Update14/03/2023 22:27:37
Status update14/03/2023 22:27:35
Last indexation30/10/2024 21:28:42
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack